Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.760
+0.010 (0.36%)
At close: Aug 28, 2026, 4:00 PM EDT
2.800
+0.040 (1.45%)
After-hours: Aug 28, 2026, 7:58 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $197.68 million as of August 28, 2026. Its market cap has increased by 24.26% in one year.
Market Cap
197.68M
Enterprise Value
88.46M
1-Year Change
24.26%
Ranking
Category
Stock Price
$2.76
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $197.68M, a decrease of -86.50%. That is a compound annual growth rate of -27.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 197.68M | 50.44% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 203.73M |
| Innate Pharma | 201.78M |
| Protalix BioTherapeutics | 199.41M |
| Satellos Bioscience | 199.27M |
| Armata Pharmaceuticals | 197.06M |
| Humacyte | 190.46M |
| Conexeu Sciences | 189.72M |
| Codexis | 180.14M |